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Executive Summary 
Microbial domain biological resource centres (mBRC) provide live cultures, their associate data and 
expertise to foster and support the development of basic and applied science. Based on a long 
tradition, individual not-for-profit mBRCs were established to add value to known and yet unknown 
microbial biodiversity and to exploit unknown sources and knowledge to discover and disclose for 
the bioeconomy and bioscience. For several decades, collaboration among some mBRCs resulted in 
the achievement of several common goals of mutual interest. The pan-European Microbial Resource 
Research Infrastructure (MIRRI) has been established to go beyond these first hesitant collaborating 
attempts.  
Directed by the MIRRI mission and user needs the current independent, often institutional policies 
and managed processes will be adapted by partner mBRCs to harmonize holdings, services, the 
training offer, accession policy and share expertise.  
Better managed resources provided with legal compliance coupled with improved interaction with 
stakeholders will lead to further discovery in all areas of the Life Sciences. Therefore, a vision of 
knowledge transfer has been outlined to offer access to human expertise, to increase knowledge and 
promote professional development, and to provide a platform for long-term sustainability of 
microbial biodiversity. The knowledge transfer will be realized through a virtual Collaborative 
Working Environment inspiring excellence and to drive collaboration across borders and disciplines.  
The following pages include the Policy on Biological Diversity and the Nagoya Protocol of the 
Microbial Resource Research Infrastructure MIRRI, a prerequisite for public mBRCs to join MIRRI as 
partners in the envisaged legal entity MIRRI-ERIC as indicated in the Partner Charter. 
For more information on MIRRI please visit our website www.mirri.org. 
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MIRRI Policy on Biological Diversity and the Nagoya Protocol 
The aim of the policy statement is to outline the principles the MIRRI-mBRCs are expected to adhere 
to with regard to utilization of the genetic resources and traditional knowledge associated with these 
genetic resources over which countries of origin have sovereign rights. It will also assist the mBRCs to 
implement institutional Access and Benefit Sharing (ABS) management policies governing daily 
practices for accession, research and transfer of material by all staff. MIRRI aims for a light general 
policy, leaving the detail of the mechanisms of compliance to the discretion of individual MIRRI-
mBRCs. 
The policy statement applies to all mBRC holdings and other biological materials, in public and non-
public collections including, but not limited to, living cultures, dried herbarium specimens, dead wet 
samples, DNA samples and other derivatives of biological material, as well as traditional knowledge 
and scientific data that are associated with these resources. 
MIRRI Policy Statement on ABS 
1. The MIRRI-mBRCs remain committed to support by all means possible the main objectives of 
the CBD, which are the conservation of biological biodiversity, the sustainable use of its 
components and the fair and equitable sharing of benefits resulting from the utilization of 
genetic resources and traditional knowledge associated with genetic resources. 
More specifically, the MIRRI-mBRCs are committed to:  
2. contribute to the conservation of biological diversity through the preservation and study of 
ex situ microbial materials and genetic resources thereof, or the encouragement and 
promotion of such study by others, in accordance with Art. 9 of the CBD; 
3. deliver, in compliance with the CBD, the Nagoya Protocol and all applicable legislation and 
regulatory requirements, well-identified, authentic and high-quality materials that are 
preserved in the public collections of the mBRCs to third parties for research and 
development, education and biotechnology, and data associated with these resources, to the 
benefit of public health, food security, and social and economic development. In doing so, 
the mBRCs also contribute to the Nagoya Protocol’s wider objective of supporting the 
conservation and sustainable use of biological diversity; 
4. present clarity on permitted use to recipients of ex situ microbial genetic resources, 
considering that these resources are the essential raw materials that drive the bio-economy, 
and while fully recognizing the sovereign rights of the countries of origin over their genetic 
resources, to refrain from posing unnecessary restrictions upon the use of these resources in 
research with commercial intent, while reminding users of applicable benefit sharing 
obligations through transfer agreements; 
5. cooperate with relevant associations of users and other interested parties in the EU and 
globally to develop procedures, tools or mechanisms that can facilitate the implementation 
of the Nagoya Protocol, stimulate the use of ex situ microbial genetic resources, and lead to 
an increase in transparency and legal certainty or a reduction in costs for both provider 
mBRCs and the users of the microbial genetic resources;  
6. design a practical and transparent legal framework that includes transfer agreements with 
model clauses, and best practice under which all MIRRI-mBRCs can operate as far as is 
permitted under applicable national law; 
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7. respect, where appropriate, the confidential nature of user information, documentation and 
administration associated with the transfer of microbial genetic resources; 
8. put institutional policies or other measures in place which assure that the mBRC staff act 
with due diligence and in full compliance with applicable national and international ABS law 
and regulatory requirements, in all collection management activities, when collecting new 
biological materials during field work, or  conducting research; 
9. inform stakeholders in general about their rights and obligations concerning ABS, where 
appropriate; 
10. share benefits arising from the utilization of the genetic resources by the mBRCs themselves, 
with the country of origin and other rightful stakeholders, in accordance with the provisions 
of the Nagoya Protocol and applicable legislation or regulatory requirements, where 
appropriate, and including, but not limited to,  
(a) adding value by generating new information on the characteristics of the genetic 
resources preserved in the mBRC’s collections, and where appropriate make this 
information publicly available through scientific and popular publications and by adding 
information to open access data repositories;  
(b) providing support to initiatives for the establishment of new ex situ collections in 
developing countries through collaborative research programs, training and other 
means of sharing expertise. 
